Correlates of benefit from neoadjuvant chemotherapy before radiotherapy in non-small cell lung cancer: a meta-analytical approach with meta-regression analysis
JOURNAL OF BUON, vol.15, no.1, pp.43-50, 2010 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 15 Issue: 1
- Publication Date: 2010
- Journal Name: JOURNAL OF BUON
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.43-50
- Keywords: chemotherapy, meta-analysis, meta-regression, neoadjuvant, non-small cell lung cancer, radiotherapy, RANDOMIZED CLINICAL-TRIALS, HIGH-DOSE RADIOTHERAPY, PHASE-III TRIAL, COMBINED CHEMORADIOTHERAPY, INDUCTION CHEMOTHERAPY, RADIATION-THERAPY, METAANALYSIS, QUALITY, CISPLATIN, PATTERNS
- Akdeniz University Affiliated: Yes
Abstract
Purpose: Induction chemotherapy before radiotherapy, although inferior to concomitant chemoradiotherapy, is still used in clinical practice, and improves survival compared to radiotherapy alone in unresectable non-small cell lung cancer (NSCLC). In this setting, we assessed the predictors of benefit from neoadjuvant chemotherapy before radiotherapy.